These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 17521693

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ.
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice.
    Chambers TJ, Jiang X, Droll DA, Liang Y, Wold WSM, Nickells J.
    J Gen Virol; 2006 Nov; 87(Pt 11):3131-3140. PubMed ID: 17030845
    [Abstract] [Full Text] [Related]

  • 6. Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice.
    Cao JX, Ni H, Wills MR, Campbell GA, Sil BK, Ryman KD, Kitchen I, Barrett AD.
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2757-64. PubMed ID: 7595383
    [Abstract] [Full Text] [Related]

  • 7. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
    Yang D, Li XF, Ye Q, Wang HJ, Deng YQ, Zhu SY, Zhang Y, Li SH, Qin CF.
    Vaccine; 2014 May 13; 32(23):2675-81. PubMed ID: 24709585
    [Abstract] [Full Text] [Related]

  • 8. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
    Yu Y.
    Vaccine; 2010 May 07; 28(21):3635-41. PubMed ID: 20226891
    [Abstract] [Full Text] [Related]

  • 9. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
    Yang J, Yang H, Li Z, Wang W, Lin H, Liu L, Ni Q, Liu X, Zeng X, Wu Y, Li Y.
    Viruses; 2017 Jan 21; 9(1):. PubMed ID: 28117725
    [Abstract] [Full Text] [Related]

  • 10. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD, Firestone CY, Whitehead SS.
    J Virol; 2015 Jun 21; 89(12):6328-37. PubMed ID: 25855730
    [Abstract] [Full Text] [Related]

  • 11. [Studies on the biological and genetic characteristics of a highly neurovirulent Japanese encephalitis virus strain SA4].
    Liu XY, Yu YX, Yue GZ, Yang LH, Jia LL, Dong GM.
    Bing Du Xue Bao; 2010 Jul 21; 26(4):265-70. PubMed ID: 20836378
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo.
    Yun SI, Song BH, Polejaeva IA, Davies CJ, White KL, Lee YM.
    J Gen Virol; 2016 Oct 21; 97(10):2575-2591. PubMed ID: 27498826
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F, Zhang ZX, Chambers TJ, Delagrave S, Arroyo J, Barrett AD, Monath TP.
    Virology; 1999 May 10; 257(2):363-72. PubMed ID: 10329547
    [Abstract] [Full Text] [Related]

  • 14. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.
    Ni H, Chang GJ, Xie H, Trent DW, Barrett AD.
    J Gen Virol; 1995 Feb 10; 76 ( Pt 2)():409-13. PubMed ID: 7844560
    [Abstract] [Full Text] [Related]

  • 15. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Yang H, Fan F, Liu L, Liu J, Sun Y, Xie A, Shi X, Liu L, Yu Y, Li Y, Ge Y, Zeng X, Yang H.
    Vaccine; 2020 Mar 04; 38(11):2636-2642. PubMed ID: 32044162
    [Abstract] [Full Text] [Related]

  • 16. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants.
    Ni H, Barrett AD.
    Virology; 1998 Feb 01; 241(1):30-6. PubMed ID: 9454714
    [Abstract] [Full Text] [Related]

  • 17. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
    Monath TP, Arroyo J, Levenbook I, Zhang ZX, Catalan J, Draper K, Guirakhoo F.
    J Virol; 2002 Feb 01; 76(4):1932-43. PubMed ID: 11799188
    [Abstract] [Full Text] [Related]

  • 18. Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
    Liu X, Zhao D, Jia L, Xu H, Na R, Ge Y, Liu S, Yu Y, Li Y.
    Vaccine; 2018 Jul 25; 36(31):4650-4656. PubMed ID: 29954631
    [Abstract] [Full Text] [Related]

  • 19. Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area.
    Wills MR, Sil BK, Cao JX, Yu YX, Barrett AD.
    Vaccine; 1992 Jul 25; 10(12):861-72. PubMed ID: 1455912
    [Abstract] [Full Text] [Related]

  • 20. Molecular characterization of attenuated Japanese encephalitis live vaccine strain ML-17.
    Shah PS, Tanaka M, Khan AH, Mathenge EG, Fuke I, Takagi M, Igarashi A, Morita K.
    Vaccine; 2006 Jan 23; 24(4):402-11. PubMed ID: 16303214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.